RISK OF CARDIOVASCULAR, GASTROINTESTINAL, AND RENAL ADVERSE EVENTS ASSOCIATED WITH DICLOFENAC IMMEDIATE AND EXTENDED RELEASE DRUG PRODUCTS: AN OBSERVATIONAL STUDY USING US CLAIMS DATA

被引：0
|
作者：
Mladsi, D. M. [1 ]
Goyal, R. K. [1 ]
Cryer, B. [2 ]
Hopkins, W. E. [3 ]
Brater, C. D. [4 ,5 ]
Korsnes, J. S. [1 ]
Candrilli, S. [1 ]
Castellsague, J. [6 ]
Varas-Lorenzo, C. [6 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] Univ Texas Southwestern & VA North Texas Hlth Car, Dallas, TX USA
[3] Univ Vermont, Coll Med, S Burlington, VT USA
[4] Walther Canc Fdn, Indianapolis, IN USA
[5] Regenstrief Fdn, Indianapolis, IN USA
[6] RTI Hlth Solut, Barcelona, Spain
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.1701
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY3
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 29 条
  • [1] Dose-Related Risks of Cardiovascular, Gastrointestinal, and Renal Adverse Events Associated with Meloxicam Among Patients with Osteoarthritis: An Observational Study Using US Claims Data
    Hoffman, Elaine
    Mladsi, Deirdre M.
    Cryer, Byron
    Hopkins, William
    Brater, D. Craig
    Parikh, Rohan
    Goyal, Ravi
    Castellsague, Jordi
    Stafkey-Mailey, Dana
    Young, Clarence
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] OBSERVATIONAL STUDY OF RESTLESS LEGS SYNDROME (RLS) AND SUBSEQUENT CARDIOVASCULAR (CV) RISK USING US CLAIMS DATA
    Richy, F.
    Makaroff, L.
    Pietri, G.
    Moorcroft, E.
    Winkelman, J.
    SLEEP, 2011, 34 : A200 - A200
  • [3] Adverse events in women switching from olaparib capsules to tablets: retrospective observational study of US claims data
    Banerjee, Susana
    Davidson, Richard
    McLaurin, Kimmie
    Sawyer, William
    Long, Grainne H.
    FUTURE ONCOLOGY, 2020, 16 (11) : 643 - 654
  • [4] Generic substitution of amlodipine is not associated with increased risk of mortality or adverse cardiovascular events: An observational cohort study
    Zhao, Boya
    Wu, Jing
    Lu, Chengzhi
    Feng, Xing Lin
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (04):
  • [5] Outcomes associated with large doses of extended and immediate release paracetamol products reported to the US National Poison Data System (NPDS)
    Reynolds, Kate M.
    Delva-Clark, Heather
    Burnham, Randy I.
    Rapp-Olsson, Malin
    Iwanicki, Janetta L.
    Dart, Richard C.
    CLINICAL TOXICOLOGY, 2019, 57 (06) : 536 - 536
  • [6] GASTROINTESTINAL INTUBATION USING A MULTI-PORT ASPIRATION CATHETER TO STUDY DRUG RELEASE OF EXTENDED-RELEASE GLIPIZIDE DRUG PRODUCTS IN THE GASTROINTESTINAL TRACT OF HEALTHY HUMANS
    Abdelnabi, Mohamed
    Watts, Lydia
    Singh, Prashant
    Li, Ruiting
    Lkhagva, Ankhbayar
    Duan, Shengnan
    Liu, Shuhan
    Wen, Bo
    Baker, Jason
    Matvekas, Aleksas
    Chey, William D.
    Hasler, William L.
    Raofi, Saeid
    Sun, Wei-Jhe
    Boyce, Heather
    Kinjo, Minori
    Pai, Manjunath
    Sun, Duxin
    Nojkov, Borko
    GASTROENTEROLOGY, 2024, 166 (05) : S385 - S386
  • [7] Risk Factors Associated With Major Adverse Cardiovascular Events Following First-Ever Ischemic Stroke: An Observational Study Using Linked Data From an Australian Stroke Registry
    Dharan, Ajay S.
    Dalli, Lachlan L.
    Kilkenny, Monique F.
    Olaiya, Muideen T.
    Cadilhac, Dominique A.
    Nedkoff, Lee
    Kim, Joosup
    Andrew, Nadine E.
    Sundararajan, Vijaya
    Kuhn, Lisa
    CIRCULATION, 2022, 146
  • [8] RELATIVE RISK OF CARDIOVASCULAR AND THROMBOTIC EVENTS AMONG PATIENTS WITH GIANT CELL ARTERITIS COMPARED WITH RHEUMATOID ARTHRITIS AND MATCHED CONTROLS: A COHORT STUDY USING US CLAIMS DATA
    Krueger, W.
    Yue, X.
    Lagunes, I.
    Setty, A.
    Ponte, C.
    Romero., A.
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [9] Diabetes is Associated With Increased Risk of Major Adverse Cardiovascular Events in Patients Covid-19: A Retrospective US Multicenter Cohort Study
    Khairani, Candrika D.
    Bejjani, Antoine
    Carroll, Brett
    Welker, James
    Bonaca, Marc P.
    Hsia, Judith A.
    Goldhaber, Samuel Z.
    Piazza, Gregory
    CIRCULATION, 2022, 146
  • [10] Treatment Patterns, Health Care Resource Utilization and Costs in Patients with Bipolar Disorder, Newly Treated with Extended Release or Immediate Release Quetiapine Fumarate using US Healthcare Administrative Claims Data
    Locklear, Julie C.
    Alemayehu, Berhanu
    Brody, Robert S.
    Chavoshi, Soheil
    Tunceli, Ozgur
    Kern, David
    Earley, Willie R.
    CLINICAL THERAPEUTICS, 2013, 35 (12) : 1923 - 1932
123